$492.69
-9.86-1.96%
At close: -
$487.00
-5.69-1.15%
After Hours: Mar 28, 7:53 PM EDT
Comments
Loading...
Vertex Pharmaceuticals Stock Guidance | NASDAQ:VRTX | Benzinga
Vertex Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/10/2025 | VRTX | Vertex Pharmaceuticals | FY | 2025 | — | — | — | $11.75B | $12.00B | $11.85B | Get Alert |
| 11/04/2024 | VRTX | Vertex Pharmaceuticals | FY | 2024 | — | — | — | $10.80B | $10.90B | $10.75B | Get Alert |
| 08/01/2024 | VRTX | Vertex Pharmaceuticals | FY | 2024 | — | — | — | $10.65B | $10.85B | $10.76B | Get Alert |
| 05/06/2024 | VRTX | Vertex Pharmaceuticals | FY | 2024 | — | — | — | $10.55B | $10.75B | $10.70B | Get Alert |
| 02/05/2024 | VRTX | Vertex Pharmaceuticals | FY | 2024 | — | — | — | $10.55B | $10.75B | $10.61B | Get Alert |
| 11/06/2023 | VRTX | Vertex Pharmaceuticals | FY | 2023 | — | — | — | $9.85B | $9.85B | $9.87B | Get Alert |
| 08/01/2023 | VRTX | Vertex Pharmaceuticals | FY | 2023 | — | — | — | $9.70B | $9.80B | $9.75B | Get Alert |
| 05/01/2023 | VRTX | Vertex Pharmaceuticals | FY | 2023 | — | — | — | $9.55B | $9.70B | $9.71B | Get Alert |
| 02/07/2023 | VRTX | Vertex Pharmaceuticals | FY | 2023 | — | — | — | $9.55B | $9.70B | $9.60B | Get Alert |
| 10/27/2022 | VRTX | Vertex Pharmaceuticals | FY | 2022 | — | — | — | $8.80B | $8.90B | $8.77B | Get Alert |
| 08/04/2022 | VRTX | Vertex Pharmaceuticals | FY | 2022 | — | — | — | $8.60B | $8.80B | $8.58B | Get Alert |
| 05/05/2022 | VRTX | Vertex Pharmaceuticals | FY | 2022 | — | — | — | $8.40B | $8.60B | $8.58B | Get Alert |
| 01/26/2022 | VRTX | Vertex Pharmaceuticals | FY | 2022 | — | — | — | $8.40B | $8.60B | $8.22B | Get Alert |
| 11/02/2021 | VRTX | Vertex Pharmaceuticals | FY | 2021 | — | — | — | $7.40B | $7.50B | $7.32B | Get Alert |
| 07/29/2021 | VRTX | Vertex Pharmaceuticals | FY | 2021 | — | — | — | $7.20B | $7.40B | $6.99B | Get Alert |
| 04/29/2021 | VRTX | Vertex Pharmaceuticals | FY | 2021 | — | — | — | $6.70B | $6.90B | $6.95B | Get Alert |
| 01/11/2021 | VRTX | Vertex Pharmaceuticals | FY | 2020 | — | — | — | $6.00B | $6.20B | $6.14B | Get Alert |
| 10/29/2020 | VRTX | Vertex Pharmaceuticals | FY | 2020 | — | — | — | $6.00B | $6.20B | $6.02B | Get Alert |
| 07/30/2020 | VRTX | Vertex Pharmaceuticals | FY | 2020 | — | — | — | $5.70B | $5.90B | $5.73B | Get Alert |
FAQ
What is the most recent guidance for Vertex Pharmaceuticals (VRTX)?
There have been no specific sales or earnings guidance reported for Vertex Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.